Bristol Myers Squibb has the first positive phase 3 results under its belt for mezigdomide, a second experimental drug in its much-trumpeted celmod development programme for multiple myeloma. Interim ...

The Chinese battery manufacturer CATL is introducing an advanced fast-charging CTP battery in Beijing for lighter cars with ...

There are few things in life as universally anxiety-inducing as the sudden, glaring illumination of the “Check Engine” light.

When [OGS Mechanics] got a Mercedes EQC 300 battery-electric car in for repair, it was found to have a bit of a weird issue: ...

DJI, the global leader in civilian drones and innovative camera technology, today launches the DJI Power 1000 Mini to the global market. At half the size of the DJI Power 1000, this is the company's ...

Bristol Myers Squibb has tapped up Faro to use AI to improve the Big Pharma's clinical trial protocols. The multi-year agreement will allow BMS to scale AI-powered workflows across trial design, ...

Bristol Myers Squibb (NYSE: BMY; BMS) delivered some good news to investors in reporting fourth-quarter and full-year 2025 results on Thursday. The pharma giant beat analyst consensus forecasts by ...

PXI/PXIe solution offers scalable, modular design for faster development cycles and lower total cost of ownership, plus improved safety CLACTON-ON-SEA, England–(BUSINESS WIRE)–Pickering Interfaces, ...

Bristol Myers Squibb, Board Chair of BMS and CEO Christopher Boerner, PhD, have committed the pharma giant to investing $40 billion over the next five years toward U.S. research and development (R&D), ...

On the heels of a clinical setback for Bristol Myers Squibb’s schizophrenia newcomer Cobenfy, the New Jersey pharma is serving up mixed results for the first three months of the year. Still, even as ...